Corporate Finance

A new report reveals how outdated laws and tech giant inaction leave survivors of online sexual abuse to fight a losing battle for justice and safety.

With a strategic investment from Headline Asia, Zettabyte aims to solve Japan's AI power crunch using its advanced software to optimize GPU performance.

After years of turmoil, Oregon's only international container terminal reopens, promising economic growth and supply chain resilience for the region.

A new partnership integrates whole-genome sequencing into a clinical trial for a novel cancer drug, promising to accelerate development and usher in a new era.

Transamerica and Empathy's new partnership signals a shift in insurance, offering comprehensive logistical and emotional support beyond a simple claim check.

Fintech firm Credibly has patented a Generative AI platform, promising faster, fairer capital access for SMBs and challenging traditional lending models.

For the third time, Lakeland Fire + Safety will supply Belgian police with safety footwear, a win showcasing product dominance and a sharp global strategy.

A new IAB study forecasts a robust 9.5% ad spend surge, driven by agentic AI, digital channel growth, and major events like the Olympics and World Cup.

A new partnership lets renters earn rewards on rent and local spending with their existing Visa cards, aiming to redefine loyalty in the housing market.

BioBridges and its legacy brands consolidate into Peritia, a new end-to-end platform designed to accelerate product development for resource-strapped teams.

Apera AI's new software promises to make factory robots smarter and faster to deploy, tackling major automation hurdles with advanced 4D Vision and AI.

A new grant funds a radical approach using AI and postmortem human brains to find crucial clues for Parkinson's therapies, aiming to crack a major medical challenge.

Dr. Marinna Madrid's new role at Cellino signals a new era for AI in medicine, as she builds both the tech and the regulatory roadmap for personalized therapies.

Following a major funding round, IgniteData appoints two clinical tech veterans to accelerate its mission of automating data flow and speeding up new therapies.

TPG's CFO Jack Weingart will address top investors, with analysts watching for signals on growth, deal-making, and navigating a complex global economy.

With a new $7.5M investment, Elysium Therapeutics is advancing SOOPR, a long-acting overdose rescue agent designed to combat the deadly fentanyl rebound.

As drug-resistant fungi pose a grave threat, SCYNEXIS presents promising data on SCY-247, a next-gen drug that could redefine the fight against infection.

Emerging from stealth with major VC backing, Limy aims to redefine digital commerce by tracking AI agents, not just human clicks, to drive revenue.

Amid a fintech downturn, Sokin lands a $100M debt facility to expand globally and build a full-stack payments operating system for businesses.

A new study in Nature Medicine shows a fasting-mimicking diet led to high remission rates in Crohn's patients, heralding a new era for 'Food as Medicine'.